SABBY MANAGEMENT, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 46 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2013$945,000
+71.2%
281,330
+62.1%
0.06%
+66.7%
Q3 2013$552,000
-9.5%
173,500
-14.1%
0.04%
-12.2%
Q2 2013$610,000202,0360.04%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,255,691$7,173,0005.84%
NEA Management Company, LLC 2,086,755$6,636,0000.26%
TOURADJI CAPITAL MANAGEMENT, LP 10,000$32,0000.10%
Loeb Offshore Management LP 101,000$321,0000.10%
BVF INC/IL 150,000$477,0000.08%
ABNER HERRMAN & BROCK LLC 20,000$64,0000.04%
SABBY MANAGEMENT, LLC 173,500$552,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 67,000$213,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 52,000$165,0000.00%
PANAGORA ASSET MANAGEMENT INC 96,858$307,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders